Subscribe

Real Clinics. Real Patients. Real Oncology.

Home / Tags / FDA Approvals

Home /

FDA Approvals

FDA Approvals

Home / Tags / FDA Approvals

Home /

FDA Approvals

Home / Tags / FDA Approvals

Home /

News / FDA Approvals

FDA Approvals

Quadruplet Regimen Approved for Transplant-Ineligible NDMM Patients

FDA approves D-VRd quadruplet for transplant-ineligible newly diagnosed multiple myeloma based on CEPHEUS trial PFS and MRD negativity gains.

April 16, 2026

Image without description (no attachment ID found)

FDA Approvals

Image without description (no attachment ID found)
FDA Approvals

Quadruplet Regimen Approved for Transplant-Ineligible NDMM Patients

April 16, 2026

Image without description (no attachment ID found)
Clinical Trials

North American Enrollment in Clinical Trials

Ming-Hei Tai, PharmD, BCOP

April 15, 2026

Image without description (no attachment ID found)
Recent Updates

FDA Launches AEMS for Adverse Event Data

April 3, 2026

Image without description (no attachment ID found)
FDA Approvals

Quadruplet Regimen Approved for Transplant-Ineligible NDMM Patients

April 16, 2026

Image without description (no attachment ID found)
Clinical Trials

North American Enrollment in Clinical Trials

Ming-Hei Tai, PharmD, BCOP

April 15, 2026

Image without description (no attachment ID found)
Recent Updates

FDA Launches AEMS for Adverse Event Data

April 3, 2026

News & Insights

Image without description (no attachment ID found)
FDA Approvals

Quadruplet Regimen Approved for Transplant-Ineligible NDMM Patients

April 16, 2026

Image without description (no attachment ID found)
Clinical Trials

North American Enrollment in Clinical Trials

Ming-Hei Tai, PharmD, BCOP

April 15, 2026

Image without description (no attachment ID found)
Recent Updates

FDA Launches AEMS for Adverse Event Data

April 3, 2026

Podcasts

No results were found

What are you
looking for?

POPULAR SEARCHES

Blood-Based Tests

Breast Cancer

Cancer Types

Cellular Therapies (e.g., CAR T)